Opendata, web and dolomites

MS-INFINITE SIGNED

MASS SPECTROMETRY WITHOUT LIMITS: Pioneer MS equipment and Automated Sample Preparation unit to boost New Therapies Development

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MS-INFINITE project word cloud

Explore the words cloud of the MS-INFINITE project. It provides you a very rough idea of what is the project "MS-INFINITE" about.

landscapes    pioneering    plan    solution    molecular    quantification    asp    medicine    despite    innovation    commercialise    calibration    analytical    business    industry    reproducibly    therapies    revenues    times    1st    ms    weight    pharmaceutical    selling    combined    specialists    2015    cancer    detectors    automated    conventional    launch    model    tool    analyte    prepare    jobs    proteins    cumulative    primary    multicomponent    alzheimer    submitted    generating    masses    heavy    size    clinical    constituents    molecules    2020    standard    drugs    spectrometry    incompatible    market    material    detection    analytes    maldi    profit    nanomedicine    life    kda    efficiency    demands    modern    viruses    macromolecules    cures    concentration    small    trials    regardless    first    too    comprising    18    estimating    11m    meet    instrumentation    enter    spectrometer    arthritis    preparation    1bn    determined    ineffective    revenue    time    patent    infinite    quantitative    rely    company    quantitatively    failing    2022    generate    tof    saving    nanoparticles    cryodetector    biotechnology    mass    roi    offers    spectrometers    experts    believe    100   

Project "MS-INFINITE" data sheet

The following table provides information about the project.

Coordinator
METEXPERT SARL 

Organization address
address: RUE DU CHATEAU 10
city: NEUCHATEL
postcode: 2000
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website https://www.metromol.ch/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    METEXPERT SARL CH (NEUCHATEL) coordinator 50˙000.00

Map

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

Modern medicine is evolving. Traditional drugs are small molecules with masses under 1 kDa. Emerging therapies increasingly rely on macromolecules 100 times this size: proteins, nanoparticles, viruses etc. Mass spectrometry is the primary tool for quantitative measurement in the pharmaceutical industry, generating revenues of €1.1Bn in 2015, but is failing to meet new demands. Conventional MS detectors become ineffective at 50 kDa making them incompatible with the emerging landscapes of biotechnology and nanomedicine. With a combined 70 years’ experience in analytical instrumentation, we plan to commercialise MS-INFINITE, our solution for large analyte mass quantification. MS-INFINITE is a multicomponent system, comprising a cryodetector MALDI-TOF mass spectrometer allowing 100% detection efficiency, regardless of molecular mass. MS-INFINITE also offers a pioneering calibration method, allowing concentration of specific constituents of large analytes to be quantitatively determined by MS for the first time (patent submitted). Through a unique business model, MS-INFINITE will generate revenue by selling an Automated Sample Preparation (ASP) unit to end-users, allowing non-specialists to reproducibly prepare clinical and pharmaceutical material for measurement. The market launch of MS-INFINITE’s ASP unit (2022) will bring the 1st revenues into our company, generating 18 new jobs, a cumulative profit of €11M, and a 5-years ROI of 5. Despite this, we believe our impact will be far more significant than company growth: MS-INFINITE has the potential to become the standard tool for quantification of analytes too heavy for existing mass spectrometers. With experts estimating that over 100 high molecular weight therapies will enter phase II or III clinical trials in 2020, our innovation will facilitate the development of pioneering advances in biotechnology and nanomedicine, allowing research to advance towards life-saving cures for cancer, Alzheimer’s and arthritis.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MS-INFINITE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MS-INFINITE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

B2BMarketplace (2019)

The first B2B marketplace for Fast Moving Consumer Goods, connecting all brand manufacturers and retailers globally

Read More  

MindTrack (2019)

Analysis of eye vergence responses for the early detection and monitoring of cognitive and mental disorders

Read More  

MHS (2019)

Metal Hydrides Hydrogen Storage

Read More